These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of vitamin D and phosphate on urinary total hydroxyproline excretion in adult-presenting "vitamin D resistant" type I renal tubular osteomalacia. Smith R, Dick M. Clin Sci; 1968 Dec; 35(3):575-87. PubMed ID: 5705812 [No Abstract] [Full Text] [Related]
6. Laboratory aids in the diagnosis of metabolic bone disease. Goldsmith RS. Orthop Clin North Am; 1972 Nov; 3(3):545-60. PubMed ID: 4344932 [No Abstract] [Full Text] [Related]
7. Total urinary hydroxyproline excretion in osteomalacia. Anderson J, Bannister DW, Parsons V, Tomlinson RW. Calcif Tissue Res; 1967 Dec 20; 1(3):183-91. PubMed ID: 5633439 [No Abstract] [Full Text] [Related]
8. Vitamin D deficiency and hyperparathyroidism. Richards AJ. Proc R Soc Med; 1972 Nov 20; 65(11):1018-9. PubMed ID: 4641997 [No Abstract] [Full Text] [Related]
9. Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia. Cohanim M, DeLuca HF, Yendt ER. Johns Hopkins Med J; 1972 Aug 20; 131(2):118-32. PubMed ID: 4340527 [No Abstract] [Full Text] [Related]
17. Anticonvulsant osteomalacia: prophylaxis with vitamin D in institutionalized adult patients. Sherk HH, Snape WT. J Med Soc N J; 1977 Jan 20; 74(1):26-9. PubMed ID: 264571 [No Abstract] [Full Text] [Related]
18. Early skeletal effect of alkali therapy upon the osteomalacia of renal tubular acidosis. Mautalen C, Montoreano R, Labarrere C. J Clin Endocrinol Metab; 1976 May 20; 42(5):875-81. PubMed ID: 1270579 [Abstract] [Full Text] [Related]